Freshpet (FRPT) director granted 1,589 restricted shares vesting in 2027

Rhea-AI Filing Summary

MCLEVISH TIMOTHY R reported acquisition or exercise transactions in this Form 4 filing.

Freshpet, Inc. director Timothy R. McLevish received an award of 1,589 shares of restricted common stock. The shares were granted at no cash cost as equity compensation and will vest on March 15, 2027, if he continues serving on the Board. Following this grant, he directly holds 36,879 shares of Freshpet common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCLEVISH TIMOTHY R

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		1,589(1)	A	$0	36,879	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

	/s/ Lisa A. Alexander, as Attorney-in-Fact for the Reporting Person	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Freshpet (FRPT) report for Timothy R. McLevish?

Freshpet reported that director Timothy R. McLevish received 1,589 shares of restricted common stock as an equity award. The grant was made at no cash cost and is part of his compensation for Board service.

When do Timothy R. McLevish’s new Freshpet (FRPT) restricted shares vest?

The 1,589 restricted Freshpet shares awarded to Timothy R. McLevish vest on March 15, 2027. Vesting is conditioned on his continued service on Freshpet’s Board of Directors through that date, according to the filing’s footnote.

How many Freshpet (FRPT) shares does Timothy R. McLevish hold after this Form 4?

After this award, Timothy R. McLevish directly holds 36,879 shares of Freshpet common stock. This total includes the newly granted 1,589 restricted shares reported in the Form 4 insider transaction filing.

Was the Freshpet (FRPT) insider transaction a market purchase or a grant?

The transaction was a grant of 1,589 restricted shares, not a market purchase. It was reported with code A, meaning a grant, award, or other acquisition under Freshpet’s 2024 Equity Incentive Plan for Board service.

Under which plan were Timothy R. McLevish’s Freshpet (FRPT) restricted shares granted?

The 1,589 restricted shares were granted under Freshpet’s 2024 Equity Incentive Plan. The award vests on March 15, 2027, provided McLevish continues to serve on the company’s Board of Directors until that date.